Upregulation of glucocorticoid receptor‐mediated glucose transporter 4 in enzalutamide‐resistant prostate cancer

Enzalutamide (Enz) is a second‐generation androgen receptor (AR) antagonist for castration‐resistant prostate cancer (CRPC) therapy, and it prolongs survival time in these patients. However, during Enz treatment, CRPC patients usually acquire resistance to Enz and often show cross‐resistance to othe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Sci
Asıl Yazarlar: Hoshi, Seiji, Meguro, Satoru, Imai, Hitomi, Matsuoka, Yuta, Yoshida, Yuki, Onagi, Akihumi, Tanji, Ryo, Honda‐Takinami, Ruriko, Matsuoka, Kanako, Koguchi, Tomoyuki, Hata, Junya, Sato, Yuichi, Akaihata, Hidenori, Kataoka, Masao, Ogawa, Soichiro, Kojima, Yoshiyuki
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2021
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088914/
https://ncbi.nlm.nih.gov/pubmed/33619826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14865
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller